Jagore Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 31-07-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.34 Cr
as on 31-07-2024
- Revenue 10.56%
(FY 2023)
- Profit -2.85%
(FY 2023)
- Ebitda 15.56%
(FY 2023)
- Net Worth 99.56%
(FY 2023)
- Total Assets 3.83%
(FY 2023)
About Jagore Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹2.34 Cr.
Udumula Venkateswarlu and Rohan Matta serve as directors at the Company.
- CIN/LLPIN
U74999TG2016PTC110264
- Company No.
110264
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Sanga Reddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jagore Life Sciences Private Limited offer?
Jagore Life Sciences Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Jagore Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Udumula Venkateswarlu  | Managing Director | 14-Jun-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohan Matta | Director | 14-Jun-2016 | Current |
Financial Performance and Corporate Structure Insights of Jagore Life Sciences.
Jagore Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.56% increase. The company also saw a slight decrease in profitability, with a 2.85% decrease in profit. The company's net worth Soared by an impressive increase of 99.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jagore Life Sciences?
In 2023, Jagore Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elena Electronics Pacific Private Limited
Active 5 years 7 monthsUdumula Venkateswarlu is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jul 2022 | ₹1.73 M | Open |
Others Creation Date: 09 Jun 2022 | ₹1.29 M | Open |
Others Creation Date: 05 Nov 2020 | ₹1.35 Cr | Open |
How Many Employees Work at Jagore Life Sciences?
Unlock and access historical data on people associated with Jagore Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagore Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagore Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
